Aberrant methylation of SPARC in human lung cancers

An Internal Review Committee at UT Southwestern Medical Center found evidence of improper replication of figures in this paper. A subsequent review by Dr Gazdar and his staff has independently confirmed the Committee’s findings.

• Publication year

  2013

• Venue

  British Journal of Cancer

• Publication date

  2013-02-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/bjc.2013.68PMID 23422791PMCID 3593569
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lung cancer in idiopathic pulmonary fibrosis

  2013cited by this paper
• Osteopontin But Not Osteonectin Messenger RNA Expression Is a Prognostic Marker in Curatively Resected Non-Small Cell Lung Cancer

  2004influential reference
• RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.

  2004cited by this paper
• Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM.

  2003cited by this paper
• Differential SPARC mRNA expression in Barrett's oesophagus

  2003influential reference
• SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor–stromal interactions

  2003influential reference
• Molecular Pathway for Cancer Metastasis to Bone*

  2003cited by this paper
• Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.

  2003influential reference
• Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression

  2003influential reference
• Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo.

  2002cited by this paper
• TGF-beta signaling: positive and negative effects on tumorigenesis.

  2002cited by this paper
• SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.

  2002cited by this paper
• Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells

  2002cited by this paper
• Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures.

  2002cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• SPARC, a matricellular protein: at the crossroads of cell-matrix communication.

  2001cited by this paper
• SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells.

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury.

  2001cited by this paper
• Analysis of the gene expression of SPARC and its prognostic value for bladder cancer.

  2001influential reference
• Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer.

  2000influential reference
• Differential expression of osteonectin/SPARC during human prostate cancer progression.

  2000influential reference
• Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.

  2000cited by this paper
• SPARC: a potential diagnostic marker of invasive meningiomas.

  1999influential reference
• SPARC, a Matricellular Glycoprotein with Important Biological Functions

  1999cited by this paper
• Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas.

  1999influential reference
• Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma

  1999influential reference
• Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.

  1999cited by this paper
• Terms of attachment: SPARC and tumorigenesis

  1997cited by this paper
• Regulation of vascular morphogenesis by the matricellular protein SPARC.

  1997cited by this paper
• Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells

  1997cited by this paper
• NCI‐navy medical oncology branch cell line data base

  1996cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology.

  1996cited by this paper
• Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin‐3 and BM‐40/SPARC genes

  1995cited by this paper
• The biology of SPARC, a protein that modulates cell‐matrix interactions

  1994cited by this paper
• SPARC is a source of copper-binding peptides that stimulate angiogenesis

  1994cited by this paper
• Overexpression of SPARC in stably transfected F9 cells mediates attachment and spreading in Ca(2+)-deficient medium.

  1992cited by this paper
• Expression of SPARC is correlated with altered morphologies in transfected F9 embryonal carcinoma cells.

  1992cited by this paper
• SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix

  1989cited by this paper
• Isolation of genomic DNA.

  1987cited by this paper

• Pre-diagnostic Demographic, Lifestyle, and Health History Factors in Association with Secreted Protein Acidic and Rich in Cysteine (SPARC) Expression in Colorectal Cancer Tissue

  2025cites this paper
• Cell-type-specific alternative polyadenylation promotes oncogenic gene expression in non-small cell lung cancer progression

  2023cites this paper
• A phase I trial of azacitidine and nanoparticle albumin bound paclitaxel in patients with advanced or metastatic solid tumors.

  2017cites this paper
• SPARC promotes cell invasion in vivo by decreasing type IV collagen levels in the basement membrane

  2016cites this paper
• SPARC Promotes Cell Invasion In Vivo by Decreasing Type IV Collagen Levels in the Basement Membrane

  2016cites this paper
• Étude de l'expression de la protéine SPARC dans une série de 60 tumeurs à cellules rénales

  2014cites this paper
• SPARC, a matricellular protein that protects cancer from therapy

  2014cites this paper
• Role of SPARC in Bone Remodeling and Cancer‐Related Bone Metastasis

  2014cites this paper
• Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis

  2014cites this paper
• Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis.

  2014cites this paper
• Revisiting the matricellular concept

  2014cites this paper
• Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?

  2013cites this paper
• First line treatment of advanced non-small-cell lung cancer – specific focus on albumin bound paclitaxel

  2013cites this paper
• Secreted Protein Acidic and Rich in Cysteine (Sparc) in Cancer

  2013influential citation
• KLF4和SPARC在非小细胞肺癌中的表达及其相关性研究

  2012cites this paper
• Aberrant DNA methylation of tumor‐related genes in oral rinse

  2012cites this paper
• Methylation of the APAF-1 and DAPK-1 promoter region correlates with progression of renal cell carcinoma in North Indian population

  2012cites this paper
• Aberrant methylation of SPARC in human hepatocellular carcinoma and its clinical implication.

  2012cites this paper
• Shortening of 3′UTRs Correlates with Poor Prognosis in Breast and Lung Cancer

  2012influential citation
• Anti-cancer role of SPARC, an inhibitor of adipogenesis.

  2011cites this paper
• THE CLINICOPATHOLOGICAL RELEVANCE FOR THE EXPRESSION OF SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE IN EPITHELIAL OVARIAN TUMORS

  2011cites this paper
• Genetic and epigenetic changes in lung carcinoma and their clinical implications

  2011cites this paper
• Improved Response to nab-Paclitaxel Compared with Cremophor-Solubilized Paclitaxel is Independent of Secreted Protein Acidic and Rich in Cysteine Expression in Non-Small Cell Lung Cancer

  2011cites this paper
• Promoter hypermethylation of the p 16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers

  year unknowncites this paper